---
figid: PMC2873028__nihms-202595-f0004
figlink: /pmc/articles/PMC2873028/figure/F4/
number: F4
caption: 'Multiple strategies are currently being employed and explored to inhibit
  the pathological activation of this pathway. Red X indicates a strategy discussed
  in the review as a potential or actively used approach for treating patients with
  disease caused as a result of VHL loss or aberrant HIF activation. These include:
  inhibition of mTOR, preventing protein synthesis of HIF, inhibition of HSP90, an
  important chaperone involved in HIF stability during cytoplasmic/nuclear shuttling,
  inhibition of cell growth in cells lacking VHL, inhibition of HIF interaction with
  transcriptional cofactors p300 and CBP, direct inhibition of targets of HIF activation,
  and inhibition of signaling receptors activated downstream of HIF transcriptional
  activation.'
pmcid: PMC2873028
papertitle: 'VHL Inactivation in Renal Cell Carcinoma: Implications for Diagnosis,
  Prognosis, and Treatment.'
reftext: W. Kimryn Rathmell, et al. Expert Rev Anticancer Ther. ;8(1):63-73.
pmc_ranked_result_index: '2970'
pathway_score: 0.9633327
filename: nihms-202595-f0004.jpg
figtitle: 'VHL Inactivation in Renal Cell Carcinoma: Implications for Diagnosis, Prognosis,
  and Treatment'
year: ''
organisms: Homo sapiens
ndex: a26af031-deb7-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2873028__nihms-202595-f0004.html
  '@type': Dataset
  description: 'Multiple strategies are currently being employed and explored to inhibit
    the pathological activation of this pathway. Red X indicates a strategy discussed
    in the review as a potential or actively used approach for treating patients with
    disease caused as a result of VHL loss or aberrant HIF activation. These include:
    inhibition of mTOR, preventing protein synthesis of HIF, inhibition of HSP90,
    an important chaperone involved in HIF stability during cytoplasmic/nuclear shuttling,
    inhibition of cell growth in cells lacking VHL, inhibition of HIF interaction
    with transcriptional cofactors p300 and CBP, direct inhibition of targets of HIF
    activation, and inhibition of signaling receptors activated downstream of HIF
    transcriptional activation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HIF3A
  - ARNTL
  - VEGFA
  - ARNT
  - CA9
  - PGF
  - ARNT2
  - FLT4
  - FLT1
  - EPAS1
  - OPN1LW
  - HSP90AB1
  - VEGFB
  - HIF1A
  - VEGFC
  - PDGFRB
  - VEGFD
  - MTOR
  - KDR
  - PDGFRA
  - HSP90B1
  - PDGFA
  - VHL
  - TRAP1
  - EP300
  - PDGFD
  - PDGFC
  - PDGFB
  - Cancer
genes:
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: CAIX
  symbol: CAIX
  source: hgnc_alias_symbol
  hgnc_symbol: CA9
  entrez: '768'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: CBP)
  symbol: CBP
  source: hgnc_prev_symbol
  hgnc_symbol: OPN1LW
  entrez: '5956'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: HIF
  symbol: HIF
  source: bioentities_symbol
  hgnc_symbol: HIF1A
  entrez: '3091'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: HIF3A
  entrez: '64344'
- word: (MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: HIFA
  symbol: HIF_alpha
  source: bioentities_symbol
  hgnc_symbol: EPAS1
  entrez: '2034'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNTL
  entrez: '406'
- word: PDGFR
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFA
  entrez: '5154'
- word: VHL
  symbol: VHL
  source: hgnc_symbol
  hgnc_symbol: VHL
  entrez: '7428'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: p300
  symbol: p300
  source: hgnc_alias_symbol
  hgnc_symbol: EP300
  entrez: '2033'
- word: HIFB
  symbol: HIF_beta
  source: bioentities_symbol
  hgnc_symbol: ARNT
  entrez: '405'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFD
  entrez: '80310'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFC
  entrez: '56034'
- word: PDGF
  symbol: PDGF
  source: bioentities_symbol
  hgnc_symbol: PDGFB
  entrez: '5155'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
figid_alias: PMC2873028__F4
redirect_from: /figures/PMC2873028__F4
figtype: Figure
---
